BI
MGNX icon

BVF Inc’s MacroGenics MGNX Stock Holding History

BVF Inc’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-200,000
Closed -$5.4M – 31
2016
Q2 		$5.4M Buy
+200,000
New +$4.51M 1.15% 23

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BVF Inc's MGNX Position: Q3 2016 in Review

BVF Inc sold out of MacroGenics (MGNX) in Q3 2016, closing a stake of 200,000 shares — an estimated $5.4M sold.

BVF Inc first reported a position in MGNX in Q2 2016 and held it in 1 quarter. The position peaked at $5.4M in Q2 2016. 132 funds tracked by Wall St. Rank hold MGNX as of Q3 2016.

  • BVF Inc reported no remaining MacroGenics position as of Q3 2016 after selling out during the quarter.
  • BVF Inc sold 200,000 MacroGenics shares in Q3 2016, an estimated $5.4M.
  • BVF Inc first reported a position in MacroGenics in Q2 2016 and held it in 1 quarter.
  • BVF Inc's MacroGenics position peaked at $5.4M in Q2 2016.
  • 132 funds tracked by Wall St. Rank held MacroGenics as of Q3 2016.

Based on BVF Inc's 13F filing for Q3 2016, filed 14 Nov 2016.